How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MK

PAR:Mauna Kea
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MK

Mauna Kea Technologies SASPAR Mauna Kea Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XPAR - Euronext Paris

FAIR VALUE

Is MKEA undervalued compared to its fair value?

The fair value of MKEA stock is hidden EUR. Relative to the market price of 0 EUR Mauna Kea Technologies SAS is hidden.

Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients....[More about valuation]

Mauna Kea Technologies SAS Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.033 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.112

FINANCIALS

Mauna Kea Technologies SAS financial for reporting period

Income Statement

0.0041 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.004 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.005 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0041 B 100%
0.0006 B 16%
-0.004 B -98%
-0.005 B -122%

Balance Sheet

0.02 B
-0.02 B

0.029 B

Financial Position Analysis

Assets

0.02 B
Current Assets
0.015 B
Total non-current assets
0.0047 B

Total current liabilities
0.013 B
Total non-current liabilities
0.027 B

Cash Flow Statement

-0.0025 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Mauna Kea Technologies SAS fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-127 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-60 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is MKEA attractive for investment based on fundamental analysis?

MKEA stock rating is hidden. Mauna Kea Technologies SAS is a hidden by Eyestock methodology.

Get MKEA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-149

Gross Margin:

10

CFO / Debt ratio:

hidden

Current ratio:

1.408

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

MKEA.PA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for MKEA.PA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Mauna Kea Technologies SAS competitors

AB

ABT

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Par...

Discover

IS

ISRG

Intuitive Surgical Inc

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company i...

Discover

SY

SYK

Stryker Corp

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. The company is ...

Discover

Mauna Kea Technologies SAS dividends

MKEA.PA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About MKEA.PA stock

About the company Mauna Kea Technologies SAS

Market cap $B

0.033

Dividend yield

Shares outstanding

44.507753 B

Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The firm focuses on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product is Cellvizio, a confocal laser endomicroscopy platform using microprobes and needles. This technological platform enables to view tissues at cellular level, in real time, during standard procedure. Cellvizio can be used in gastroenterology, pulmonology, or urology. The firm markets its technological platform in more than 40 countries, including the United States, Europe, Japan, China, South Korea as well as several Latin American countries.

MKEA.PA profile

  • Ticker

    MKEA.PA

  • Country

    France

  • Exchange

    XPAR - Euronext Paris

  • Report currency

    EUR - Euro

  • IPO date

    05 July 2011

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

    67

  • City

    Paris

  • Address

    9, rue d'Enghien

  • Cusip

    F6099Z105